Organ transplantation in Göteborg with particular reference to kidney transplantation.
The limiting factor in organ transplantation is the availability of organs. Continuing work to improve the public's willingness to donate organs and inspire hospital staff to collaborate in organ procurement is essential. Identification of patients who will not benefit from transplantation can also increase the availability of organs. Grafts may also be saved by identification and appropriate treatment of recurrent renal disease. Xenotransplantation may eventually solve the problem, but major obstacles remain. Meanwhile, work in this field may help to clarify mechanisms of rejection. New immunosuppressive drugs may improve graft survival and reduce the incidence and progression of chronic rejection.
Tufveson
G
G
Division of Transplantation and Liver Surgery, Sahlgrenska Hospital, University of Göteborg, Sweden.
Bäckman
L
L
Berglin
E
E
Blohmé
I
I
Breimer
M
M
Friman
S
S
Holmberg
S
S
Lindnér
P
P
Mjörnstedt
L
L
Nordén
G
G
D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D000368:Aged; D000818:Animals; D001787:Blood Group Incompatibility / Q000276:immunology; D016027:Heart Transplantation / Q000706:statistics & numerical data; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology / Q000706:statistics & numerical data; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000706:statistics & numerical data; D012086:Reoperation; D013548:Sweden; D009927:Tissue and Organ Procurement; D014183:Transplantation, Heterologous
D000017:ABO Blood-Group System